Hematopoietic and immune regulatory proteins

Hematopoietic and immune regulatory proteins represent a broad and essential class of signaling molecules, primarily comprising cytokines and growth factors, that govern the production, maturation, and functional activity of blood and immune cells. This category includes diverse families such as interleukins, interferons, colony-stimulating factors, and chemokines, which act through specific cell-surface receptors to initiate critical intracellular signaling pathways, most notably the JAK-STAT pathway. These proteins are fundamental to maintaining hematopoietic homeostasis, coordinating the body's response to infection, and mediating inflammatory processes. Dysregulation of these regulatory networks is a central feature in the pathogenesis of numerous conditions, including hematologic malignancies, autoimmune disorders, and chronic inflammatory diseases. Consequently, this class is a major focus of therapeutic development; recombinant proteins are used to supplement deficiencies (e.g., erythropoietin for anemia), while monoclonal antibodies and inhibitors are employed to neutralize overactive signaling in conditions like rheumatoid arthritis or cytokine release syndrome.

Other names

CytokinesHematopoietic growth factorsImmunomodulatory proteinsImmune regulatory factorsHematopoietic and immune regulatory cytokines

Drugs targeting this class typically act as recombinant agonists to stimulate the production of specific blood cell lineages or as monoclonal antibodies and decoy receptors to inhibit the signaling of pro-inflammatory cytokines involved in disease pathology.